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Introduction
Formation of new blood vessels from preexisting vessels, i.e., 
angiogenesis, encompasses a series of morphogenic events 
that include sprouting at the vascular front, branching, lumen 
formation, anastomoses, and remodeling into a hierarchically 
patterned and functionally perfused vascular network (1, 2). 
Because sprouting at the vascular front is a frontline, critical 
process in both physiological and pathological angiogenesis, 
understanding the sprouting is of primary interest for controlling 
angiogenesis. In the vascular front, endothelial cells (ECs) are 
exposed to numerous angiogenic stimuli, such as growth factors 
including VEGF-A (hereafter VEGF) and cytokines, and adopt 
specific phenotypes and functions, such as tip ECs and stalk ECs, 
to coordinate their behaviors for regulating sprouting (1, 3–5). 
Tip ECs directionally migrate into the avascular area with exten-
sion of long, dynamic actin-based filopodia. They use filopodia 
to sense their surroundings for guidance cues and to steer the 
sprouts in a certain direction (1, 3–5). Trailing the tip ECs, stalk 
ECs proliferate to supply building blocks for growing sprouts. 
As the vessel elongates, stalk ECs establish tight and adherens 
junctions to ensure the integrity of new sprouts, create a vascular 
lumen, deposit a basement membrane, and associate with mural 
cells (1, 3–5). To regulate such delicate and complex processes, 
several key ligands/receptors, including VEGF/VEGFR, DLL4/
Notch, angiopoietin/TIE2, Wnt/Frizzled, PDGF/PDGFR, and 
cell matrix/integrin, are critically and coordinately involved (1). 
However, key and selective transcriptional factors are beginning 
to be explored that mediate the signaling responses and control 
multiple aspects of EC behaviors for sprouting.
Yes-associated protein (YAP) or its paralog transcriptional 
coactivator with PDZ-binding motif (TAZ; also known as WWTR1) 
is a transcription coactivator that mainly interacts with the TEAD/
TEF family of transcription factors and plays crucial roles in regu-
lating proliferation, differentiation, and migration of cells, tissue 
growth, and organ morphogenesis (6, 7). The Hippo pathway is a 
key upstream regulator of YAP/TAZ, limiting its activity through 
phosphorylation-dependent cytoplasmic retention and destabili-
zation (6, 7). Interestingly, recent studies have shown that YAP/
TAZ mediates a wide range of cellular signals, including cell-cell 
contact, cell polarity, mechanical cues, secreted mitogens, and 
cellular metabolic status (6, 8–10), which all are also coordinately 
required for regulating angiogenesis. Moreover, YAP/TAZ plays 
pivotal roles in branching morphogenesis of lung airway and kid-
ney ureteric duct (11, 12), which have structural and functional sim-
ilarities with the branching morphogenesis of blood vessels during 
angiogenesis. Indeed, earlier studies (13–16) have revealed that 
core components of the Hippo pathway are involved in regulating 
vasculogenesis (building primitive vascular plexus with heman-
gioblasts) and angiogenesis during embryonic development. Pre-
vious studies (17, 18) have demonstrated that endothelial YAP 
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mice. When Yap/Taz was specifically deleted in ECs of Yap/TaziΔEC 
mice from P2, the mice at P5 showed delayed vessel growth and a 
hyper-pruned vascular network that contained fewer ECs without 
vascular leakage in the retina compared with those of WT mice 
(Figure 1, B and C). This result indicated that endothelial YAP/
TAZ contributes substantially to enhancing sprouting angiogen-
esis and vascular network formation in retina during the early 
postnatal period (birth to P5). In comparison, single deletion of 
Yap or Taz in growing retinal vessels using YapiΔEC mice or TaziΔEC 
mice showed far less abnormal vascular phenotypes compared 
with Yap/TaziΔEC mice, indicating a certain degree of functional 
redundancy between YAP and TAZ in retinal vessel growth (Sup-
plemental Figure 3).
Strikingly, the tip ECs in the vascular front region of Yap/
TaziΔEC mice exhibited a blunted-end, aneurysm-like structure 
with fewer and dysmorphic filopodia compared with those of WT 
mice (Figure 1, D and E). The tip ECs of Yap/TaziΔEC mice had no 
organized F-actin bundle–containing protrusions (highlighted by 
phalloidin staining) and defective lumen formation (outlined by 
ICAM2 distribution), while those of WT mice had fine actin fila-
ment bundles protruding along filopodia and proper lumen forma-
tion (Figure 1F). These findings imply that YAP/TAZ plays crucial 
roles in sprouting by regulating rearrangement of cytoskeletal pro-
teins, particularly in the tip ECs.
We confirmed markedly reduced levels of YAP and TAZ in 
the ECs of retinal vessels of the Yap/TaziΔEC mice (Supplemen-
tal Figure 4, A and B). Moreover, angiopoietin-2 (ANGPT2) and 
endothelial cell–specific molecule 1 (ESM1), which are tip EC 
markers as well as positive regulators of sprouting angiogenesis, 
but not VEGFR2, were markedly reduced in the vascular front of 
Yap/TaziΔEC mice compared with WT mice (Supplemental Figure 
4, C–G). Furthermore, significantly fewer ETS-related gene–
positive (ERG+) ECs and phospho–histone H3–positive (pHH3+) 
proliferating ECs were found, but cleaved-caspase-3–positive 
(cl-CASP3+) apoptotic ECs, PDGFRβ+ pericyte coverage onto 
ECs, and distribution of collagen IV–positive (COL4+) basement 
membrane along ECs in the retinal vessels of Yap/TaziΔEC mice 
were similar to those of WT mice (Figure 1, G and H, and Sup-
plemental Figure 4, H and I).
Importantly, endothelial deletion of Yap/Taz from the 
embryo using Yapfl/fl Tazfl/fl Tie2-Cre (Yap/TazΔTie2) mice resulted 
in a severe impairment in vessel formation that led to embryonic 
lethality around embryonic day 9.5 (E9.5) (Supplemental Figure 
5). Interestingly, YAP and TAZ were highly distributed in nuclei 
of ECs in dorsal skin at E14.5, which migrate toward dorsal mid-
line (Supplemental Figure 6A). When Yap/Taz was specifically 
deleted in ECs of Yap/TaziΔEC mice from E9.5, the mice showed 
delayed capillary anastomosis with blunted vascular front and 
reduced branching with enlarged vessels in the dorsal skin com-
pared with those of WT mice at E14.5 (Supplemental Figure 6, 
B–D). Thus, YAP/TAZ plays multiple roles in angiogenesis in an 
EC-autonomous manner.
Endothelial YAP/TAZ hyperactivation induces excessive filopodia 
and hyperplastic vascular growth. LATS1 and LATS2 kinases have 
a high degree of sequence homology and functional overlap and 
directly phosphorylate and inhibit the activities of YAP/TAZ canon-
ically in the Hippo pathway (6, 7). To further elucidate the roles of 
activity can be modulated by an adherens junction complex, such 
as VE-cadherin and its adaptor EPS8, and regulates angiogenic 
activity of ECs. Moreover, a disturbed flow causes YAP/TAZ acti-
vation in ECs, leading to promotion of EC proliferation, inflamma-
tion, and atherogenesis (19, 20). Furthermore, a recent report (21) 
has shown that YAP can be activated by a flow-induced mechan-
ical stress, which is independent of the Hippo pathway. However, 
the exact roles of YAP/TAZ and their mechanisms in angiogenesis 
and vascular remodeling in vivo remain unclear.
Here, we show that YAP/TAZ plays essential roles in sprout-
ing angiogenesis and vascular barrier maturation. YAP/TAZ is 
critically required for migration and filopodia formation of tip 
ECs and proliferation of stalk ECs by regulating actin cytoskel-
eton remodeling and the metabolic activity of ECs. We further 
show that YAP/TAZ has a crucial role for maturation of the vas-
cular barrier in retina and brain by regulating the expression 
and distribution of junctional and extracellular matrix (ECM) 
proteins and actomyosin contractility of ECs. Finally, using a 
mouse model of laser-induced choroidal neovascularization, 
we demonstrate that YAP/TAZ is also critically involved in 
pathological angiogenesis.
Results
Endothelial YAP/TAZ plays a promoting role in sprouting angio-
genesis. To gain an insight into the role of YAP/TAZ in blood ves-
sels, we first examined its expression in several organs in normal 
C57BL/6J mice. YAP was highly enriched in growing vessels of 
retina and brain at postnatal day 5 (P5) (Supplemental Figure 1, 
A and C; supplemental material available online with this article; 
https://doi.org/10.1172/JCI93825DS1). Notably, YAP was highly 
but diffusely distributed in the cytoplasm and nuclei of ECs, while 
TAZ was highly distributed in the nuclei of ECs, at the vascular 
front, and in the vascular plexus of retinal vessels (Supplemen-
tal Figure 1A and Supplemental Figure 2). The publicly available 
microarray data (22) also revealed that YAP and its target genes 
are enriched in both tip and stalk ECs compared with non-ECs 
such as pericytes, astrocytes, and neuronal cells in retina (Supple-
mental Figure 1B). Further immunohistologic analysis revealed 
that YAP distribution was markedly reduced in the vascular plexus 
at P12 and in both peripheral and central regions of retinal vessels 
at adulthood (Supplemental Figure 2), and TAZ distribution was 
also markedly reduced at P12, and was barely detectable at adult-
hood (Supplemental Figure 2). Moreover, both YAP and TAZ were 
highly detectable in both cytoplasm and nuclei of ECs of cerebral 
cortex in brain at P5, but were reduced at P12 and further reduced 
at adulthood (Supplemental Figure 2). In contrast, while they were 
not highly detectable in ECs, they were highly and mainly distrib-
uted in nuclei of non-ECs in heart and liver at P5 and P12 (Supple-
mental Figure 2). These findings suggest that YAP and TAZ may 
play substantial roles in sprouting angiogenesis at the vascular 
front in retina and vessel maturation in brain in response to vari-
ous stimuli during postnatal development.
Next, to investigate the roles of YAP/TAZ in growing retinal 
vessels, we generated a Yap/TaziΔEC mouse by crossing Yapfl/fl/Tazfl/fl 
(23, 24) mice with VE-cadherin–CreERT2 mice (ref. 25 and Fig-
ure 1A). CreERT2-positive but flox/flox-negative mice among the 
littermates for each experiment were defined as wild-type (WT) 
Downloaded from http://www.jci.org on December 17, 2017.   https://doi.org/10.1172/JCI93825
The Journal of Clinical Investigation   R E S E A R C H  A R T I C L E
3 4 4 3jci.org   Volume 127   Number 9   September 2017
Figure 1. Endothelial YAP/TAZ is a crucial regulator of vascular sprouting and growth. (A) Diagram for EC-specific depletion of YAP/TAZ in retinal vessels from 
P2 and their analyses at P5 using Yap/TaziΔEC mice. (B and C) Images of CD31+ retinal vessels and comparisons of indicated parameters in WT and Yap/TaziΔEC 
mice (n = 5, each group). Scale bars: 500 μm. (D and E) Magnified images and comparisons of retinal vessels in the vascular front region of WT and Yap/TaziΔEC 
mice at P5 (n = 5, each group). Tip ECs in Yap/TaziΔEC mice exhibit an aneurysm-like structure with less and dysmorphic filopodia (yellow arrowheads). Scale bars: 
100 μm, top panels; 50 μm, bottom panels. (F) Images showing phalloidin+ actin filament (F-actin) bundle and ICAM2+/collagen IV+ (COL4+) lumen formation in 
tip ECs of WT and Yap/TaziΔEC mice. No organized F-actin bundle–containing protrusions and defective lumen formation (white arrowhead) are detected in tip 
ECs of Yap/TaziΔEC mice. Scale bars: 50 μm. (G and H) Images and comparisons of ERG+ ECs, pHH3+ proliferating ECs (white arrowheads), and cl-CASP3+ apoptotic 
ECs in WT and Yap/TaziΔEC mice (n = 5, each group). Scale bars: 100 μm. Error bars represent mean ± SD. *P < 0.05 vs. WT by Mann-Whitney U test.
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macrophage infiltration with increased plasmalemma vesicle–
associated protein (PLVAP, a marker of barrier permeability; ref. 
31), reduced tight junction proteins ZO1 and claudin-5, and dis-
arranged VE-cadherin were found in the retinas of Yap/TaziΔEC 
mice compared with those of WT mice (Figure 3, H and I). Nev-
ertheless, no differences were found between the 2 mouse strains 
in coverage of PDGFRβ+ pericytes onto ECs in the retinal vessels 
(Figure 3, H and I). Importantly, these severe vascular defects and 
their consequences were sustained until P21 and led to severe 
vision impairment (Figure 4). Thus, YAP/TAZ is critically involved 
in formation and maturation of the blood-retinal barrier (BRB) in 
an EC-autonomous manner.
Endothelial YAP/TAZ is required for formation and matura-
tion of the vascular network in the brain. Taking advantage of EC- 
specific deletion of Yap/Taz in a tamoxifen-inducible manner, we 
further evaluated whether these vascular defects occurred in other 
organs of Yap/TaziΔEC mice at P12. Although severe growth retar-
dation and lethality were observed, most organs did not show evi-
dent vascular defects (Supplemental Figure 8, A–E). Nevertheless, 
weights of major organs and lengths of long bones were less in 
Yap/TaziΔEC mice compared with those of WT mice (Supplemental 
Figure 8, F–I). However, the density and budding of blood vessels 
in the metaphysis, the number of Osterix+ osteoprogenitors, and 
the formation of secondary ossification center in the epiphysis of 
Yap/TaziΔEC mice were not significantly different from those of WT 
mice (Supplemental Figure 8, J and K). These data suggest that the 
growth retardation in Yap/TaziΔEC mice might have resulted from 
malnutrition due to insufficient milk intake.
In contrast, the brains of Yap/TaziΔEC mice exhibited striking, 
extensive, and multifocal hemorrhages, particularly in cerebral 
striatum, nuclei, and cerebellum at P12 (Figure 5, A–D). Further 
analyses revealed that substantial TER119+ rbc leakage and F4/80+ 
macrophage infiltration together with extensive vascular leakage 
were detected in the multifocal regions of brains of Yap/TaziΔEC 
mice (Figure 5, E–J). Detailed histologic analyses demonstrated 
less vascular density with tortuous and enlarged capillaries and 
numerous microaneurysm formations at the vascular branching 
region in the brains of Yap/TaziΔEC mice (Figure 6, A–C). Strikingly, 
the tip ECs in the vascular front region of the brain in Yap/TaziΔEC 
mice exhibited blunted-end, microaneurysm-like structures with 
almost no filopodia (Figure 6, D and E), which coincided with the 
phenotypes in tip ECs of the retinal vessels. Increased PLVAP and 
reduced transferrin receptor (TfR) but no changes in glucose trans-
porter 1 (GLUT1) (markers for blood-brain barrier integrity; ref. 32) 
nor in PDGFRβ+ pericyte coverage onto ECs were also found in the 
brains vessels of Yap/TaziΔEC mice compared with those of WT mice 
(Figure 6, F and G). We confirmed efficient endothelial deletion of 
YAP/TAZ in vascular growth, we hyperactivated YAP/TAZ in the ret-
inal vessels using Lats1/2iΔEC mice, which were generated by crossing 
of Lats1fl/fl (26, 27) and Lats2fl/fl (28) mice with VE-cadherin–CreERT2 
mice (Figure 2A). Lats1/2iΔEC mice showed a dense and hyperplastic 
retinal vascular network but reduced radial length due to uncoor-
dinated vascular outgrowth (Figure 2, B and C). In fact, Lats1/2iΔEC 
mice showed numerous filopodial bursts emerging from tip ECs at 
the vascular front and an increased number of ERG+ ECs and pHH3+ 
proliferating ECs, especially in the peripheral vascular plexus (Fig-
ure 2, D and E). Gene set enrichment analysis (GSEA) on the freshly 
isolated lung ECs confirmed the upregulation of YAP signature 
genes in Lats1/2iΔEC mice compared with WT mice (Figure 2F). Nota-
bly, these phenotypes of Lats1/2iΔEC were almost completely abol-
ished in the retinal vessels of Lats1/2-Yap/TaziΔEC mice, which were 
generated by crossing of the Lats1/2iΔEC mice and double Yapfl/fl/Tazfl/fl 
mice (Figure 2, D and E). YAP signature genes on the ECs were 
downregulated in Lats1/2-Yap/TaziΔEC compared with Lats1/2iΔEC 
mice (Figure 2G). These findings indicate that YAP/TAZ is canoni-
cally modulated by LATS1/2 in the growing vessels and that endo-
thelial YAP/TAZ hyperactivation induces excessive filopodia and 
hyperplastic vascular growth.
To address the unique roles of YAP/TAZ in tip EC formation 
and stalk EC proliferation, we treated Yap/TaziΔEC mice at P4 and P5 
with the γ-secretase inhibitor DAPT and analyzed the retinal vessels 
at P6 (Supplemental Figure 7A). As expected (29, 30), the retinal 
vessels of WT mice treated with DAPT showed excessive sprout-
ing, enhanced EC proliferation, and a highly dense vascular plexus. 
In contrast, the unique phenotypes in the retinal vessels of Yap/
TaziΔEC mice had not been apparently altered by DAPT treatment 
(Supplemental Figure 7, B and C). These findings indicate that YAP/
TAZ plays dominant roles in governing both tip EC formation and 
stalk EC proliferation by modulating signaling activated by multiple 
angiogenic cues.
Endothelial deletion of Yap/Taz leads to sustained and severe 
impairments in the formation and maturation of blood-retinal bar-
rier and vision. For further determination of the role of Yap/Taz in 
growing retinal vessels, YAP/TAZ was deleted in the ECs from P2 
in Yap/TaziΔEC mice, and the retinas were analyzed at P12 (Figure 
3A). Severe and extensive retinal and vitreous hemorrhages and 
profound leakage of Evans blue dye were found in the retinas of 
Yap/TaziΔEC mice (Figure 3, B and C). Moreover, in the retinas of 
Yap/TaziΔEC mice, there were substantially reduced vessel out-
growth and vascular density, enlarged and tortuous vessels, a rel-
atively large avascular area at the periphery, multiple microaneu-
rysms with no vertical sprouts in the superficial vascular plexus, 
and no vascular network in the deep vascular plexus (Figure 3, 
D–G). As a consequence, severe TER119+ rbc leakage and F4/80+ 
Figure 2. Endothelial Lats1/2 deletion causes dense and hyperplastic vascular network in growing retinal vessels, and their phenotypes are vanished by 
endothelial Yap/Taz codeletion. (A) Diagram for EC-specific deletion of Lats1/2 and double deletions of Lats1/2 and Yap/Taz in retinal vessels from P2 and 
their analyses at P5 in Lats1/2iΔEC and Lats1/2-Yap/TaziΔEC mice. (B and C) Images of CD31+ retinal vessels and comparisons of indicated parameters in WT, 
Lats1/2iΔEC, and Lats1/2-Yap/TaziΔEC mice (n = 4, each group). Scale bars: 500 μm. (D and E) Images and comparisons of CD31+ retinal vessels in the vascular 
front region, ERG+ ECs, and pHH3+ proliferative ECs in WT, Lats1/2iΔEC, and Lats1/2-Yap/TaziΔEC mice (n = 4, each group). Scale bars: 100 μm. (F) GSEA of isolated 
lung ECs showing the upregulation of YAP signature genes in Lats1/2iΔEC compared with WT mice, and corresponding heatmaps of the top 15 enriched genes. 
ES, enrichment score; NES, normalized enrichment score. (G) GSEA of isolated lung ECs showing the downregulation of YAP signature genes in Lats1/2-Yap/
TaziΔEC compared with Lats1/2iΔEC mice, and corresponding heatmaps of the top 15 enriched genes. Error bars represent mean ± SD. *P < 0.05 vs. WT, #P < 0.05 
vs. Lats1/2iΔEC by Mann-Whitney U test.
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YAP by GSEA in the isolated brain ECs and by immunohistochem-
istry in brain vessels of Yap/TaziΔEC mice (Figure 6, H and I, and 
Supplemental Figure 8L).
It is especially notable that Yap/TaziΔEC mice had disarranged 
distributions and reduced levels of the tight junction proteins 
ZO1 and claudin-5 and the adherens junction protein VE- 
cadherin in the ECs of brain vessels (Figure 7, A–D). Moreover, 
among the ECM proteins of BBB, markedly reduced depositions 
of laminin and perlecan, ECM proteins of the blood-brain bar-
rier (BBB), without changes in collagen IV and nidogen, were 
found along the brain capillaries in Yap/TaziΔEC mice compared 
with those of WT mice (Figure 7, E and F). mRNA expression 
of the genes involved in inflammation and hypoxia (Ccl2, Ccl3, 
Arg1, Tnfa, Il6, and Il10) was highly upregulated, but there were 
no changes in Vegf mRNA in the brains of Yap/TaziΔEC mice com-
pared with those of WT mice (Figure 7G). Moreover, associations 
with the Gene Ontology (GO) terms “cell junction assembly” 
and “extracellular structure organization” were also reduced in 
brain ECs of Yap/TaziΔEC mice compared with those of WT mice 
(Figure 7H). Together, these results indicate that YAP/TAZ plays 
multifaceted roles in vascular sprouting and network formation 
and in BBB maturation in the brain.
YAP/TAZ controls EC migration and filopodia/lamellipodia for-
mation by regulating actomyosin cytoskeleton. To obtain mechani-
cal insights into how YAP/TAZ regulates sprouting angiogenesis 
and vascular remodeling, we performed a series of in vitro anal-
yses in primary cultured HUVECs. Because VEGF is a key player 
governing sprouting angiogenesis (1–3) and recent reports (9, 33) 
demonstrate that mitogenic growth factors such as EGF activate 
YAP/TAZ mediated through the PI3K/PDK1/Hippo pathway, we 
hypothesized that VEGF might regulate YAP/TAZ activity in ECs 
or vice versa. Intriguingly, VEGF stimulation facilitated a nuclear 
localization of YAP in HUVECs (Figure 8, A and B). This finding 
was in accordance with the increase in VEGFR2 phosphoryla-
tion (at Tyr1175) and reductions in LATS1 phosphorylation (at 
Thr1079) and YAP phosphorylation (at Ser127; site that is phos-
phorylated by LATS1 as well as being responsible for cytoplasmic 
sequestration of YAP) (Figure 8, C and D). Thus, activation of 
VEGF/VEGFR2 signaling seems to promote the nuclear localiza-
tion of YAP through the canonical Hippo pathway (6, 7). Moreover, 
mRNA levels of CTGF and CYR61, bona fide YAP target genes (34), 
were also increased in HUVECs after VEGF stimulation (Figure 
8E), consistent with previous findings (ref. 35 and Figure 8F). We 
then examined EC behaviors and their actin cytoskeleton using 
the HUVECs transfected with siControl (siCont-ECs) or siYAP/
TAZ (siYAP/TAZ-ECs). Upon VEGF stimulation, siYAP/TAZ-ECs 
had significantly reduced migration, smaller lamellipodia, and 
fewer filopodia compared with siCont-ECs (Figure 9, A–D). siYAP/ 
TAZ-ECs had no significant alterations in VEGF-induced phos-
phorylation of VEGFR2, AKT, ERK, eNOS, PAK2, or FAK com-
pared with siCont-ECs (Figure 9E). However, among the small 
Rho GTPases, VEGF-stimulated enhanced CDC42 activity was 
markedly attenuated without changes in the activities of RhoA 
and Rac1 in siYAP/TAZ-ECs compared with siCont-ECs (Figure 
9F). Further analysis revealed that this selective attenuation of 
CDC42 activity was presumably caused by substantially reduced 
CDC42 protein level in siYAP/TAZ-ECs (Figure 9, G and H). In 
addition, compared with siCont-ECs, siYAP/TAZ-ECs had mark-
edly reduced protein level of MLC2 (also known as MYL9) with-
out changes in the protein levels of MYH9 and MYH10 (Figure 9I). 
Consistent with this finding, markedly reduced pMLC2 (at Ser19) 
was detected in growing retinal vessels of Yap/TaziΔEC mice com-
pared with those of WT mice (Figure 9, J and K).
Moreover, GSEA revealed that association with the GO term 
“regulation of actin filament based movement” was decreased 
in the brain ECs of Yap/TaziΔEC mice compared with those of WT 
mice (Figure 9L). These results indicate that YAP/TAZ regulates 
EC migration and filopodia/lamellipodia formation by modulat-
ing actomyosin cytoskeleton in response to VEGF.
YAP/TAZ regulates EC proliferation and metabolic activity through 
MYC signaling. Given that metabolic activity is a critical regulator 
for proliferation and migration of ECs during angiogenic sprout-
ing (36–38), we then asked whether YAP/TAZ regulates metabolic 
activity in the HUVECs. Growth of siYAP/TAZ-ECs was markedly 
retarded by cell cycle arrest at G1 (Figure 10, A and B). Indeed, com-
pared with siCont-ECs, siYAP/TAZ-ECs had marked reductions in 
both glycolysis and mitochondrial oxidative phosphorylation (Fig-
ure 10, C–F). Moreover, GSEA demonstrated downregulation of the 
genes related to E2F targets, glycolysis, and oxidative phosphory-
lation in the isolated brain ECs of Yap/TaziΔEC mice compared with 
WT mice (Supplemental Table 1 and Figure 10G). Notably, molec-
ular and biochemical analyses revealed no differences in apoptosis, 
energy distress, senescence, or autophagy between siCont-ECs and 
siYAP/TAZ-ECs (Supplemental Figure 9, A–F). These results indi-
cate that YAP/TAZ plays important roles in EC proliferation and 
metabolism. In particular, MYC target gene signatures were down-
regulated in the ECs of Yap/TaziΔEC mice compared with WT mice 
(Supplemental Table 1, Figure 10H, and Supplemental Figure 9G).
Because MYC is a powerful driver of glycolysis, mitochon-
drial metabolism, and cell growth (39, 40), we speculated that 
YAP/TAZ could modulate expression and activity of MYC in 
ECs. YAP/TAZ depletion suppressed protein level of MYC but 
Figure 3. Endothelial Yap/Taz deletion impairs formation of vertical branching and barrier integrity in retina. (A) Diagram depicting the experiment 
schedule for EC-specific deletion of Yap/Taz in retinal vessels from P2 and their analyses at P12 in Yap/TaziΔEC mice. (B and C) Images of inner sur-
face of retinal cup and comparison of blood island area of WT and Yap/TaziΔEC mice (n = 4, each group). Vitreous and retinal hemorrhage (arrows) and 
Evans blue (EB) leakage (bottom panels) are detected in Yap/TaziΔEC mice. (D and E) Images of CD31+ vessels in superficial and deep layers of retinas 
and comparisons of indicated parameters in WT and Yap/TaziΔEC mice (n = 4, each group). Scale bars: 500 μm. (F and G) 3D reconstructed images of 
CD31+ vascular plexus and comparison of number of microaneurysms in WT and Yap/TaziΔEC mice (n = 4, each group). Multiple microaneurysms (yellow 
arrowheads) but no vertical branch and deep vascular plexus are observed in Yap/TaziΔEC mice. Scale bars: 100 μm. (H and I) Images and comparisons of 
TER119+ rbc leakage, F4/80+ macrophage infiltration, PDGFRβ+ pericyte coverage onto CD31+ vessels, level of PLVAP on CD31+ vessels, and distributions 
of VE-cadherin, ZO1, and claudin-5 on CD31+ vessels in retinas of WT and Yap/TaziΔEC mice (n = 4, each group). Scale bars: 100 μm. Error bars represent 
mean ± SD. *P < 0.05 vs. WT by Mann-Whitney U test.
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localization of TAZ in the vascular front of the retina, where flow 
is absent but a strong VEGF gradient toward the front is present. In 
support of this observation, our biochemical analyses in primary 
cultured HUVECs revealed that activation of VEGF/VEGFR2 sig-
naling appears to promote nuclear localization of YAP through the 
canonical Hippo pathway (6, 7). Therefore, VEGF may be one of the 
major blood flow–independent stimuli that activate YAP/TAZ in 
ECs in the vascular front area of growing vessels, which promotes 
sprouting angiogenesis.
We note that the unique vascular phenotypes in Yap/TaziΔEC 
mice are very similar to those of SrfiΔEC and MrtfiΔEC mice (42–44), 
which have an EC-specific deletion of serum response factor (Srf) 
or its transcriptional cofactor myocardin-related transcriptional 
factor (Mrtf). Like the alterations in retinal vessels of Yap/TaziΔEC 
mice, SrfiΔEC and MrtfiΔEC mice exhibit blunted-end, aneurysm-like 
structures with impaired filopodia protrusion of tip ECs, incom-
plete formation of the primary vascular plexus, and an absence 
of the deep plexus. Interestingly, both MRTF and YAP/TAZ use 
substantially overlapping regulation mechanisms in response to 
mechanical signals (10, 45). Moreover, there are multiple levels 
of crosstalk between the MRTF-SRF and YAP/TAZ–TEAD cas-
cades (46–50). In fact, both MRTF-SRF and YAP/TAZ signature 
genes substantially overlap, and hundreds of these genes are crit-
ically involved in actin cytoskeleton–mediated processes such as 
cell motility, actin dynamics, cell adhesion, and ECM synthesis 
(46). Therefore, it is tempting to speculate that YAP/TAZ–TEAD 
and MRTF-SRF may act together to coordinate transcriptional 
responses to various cellular stimuli, particularly for sprouting 
angiogenesis. Indeed, our preliminary GSEA revealed that the 
MRTF signature genes are significantly downregulated in the brain 
ECs isolated from Yap/TaziΔEC mice (data not shown), emphasiz-
ing a potential molecular interaction between YAP/TAZ and 
MRTF-SRF in the ECs of growing vessels. Nevertheless, unlike the 
phenotype of SrfiΔEC mice (42, 44), a proliferation activity of the 
stalk ECs is markedly reduced in the retinal vessels of Yap/TaziΔEC 
mice. ANGPT2 and ESM1 are highly enriched in the tip ECs (51), 
and their expressions are regulated by FOXO1 (52, 53), while the 
former is regulated by YAP (17). However, the phenotypes of grow-
ing retinal vessels of Angpt2iΔEC (54) and Esm1iΔEC (55) mice are dif-
ferent and pathologically milder than those of Yap/TaziΔEC mice. 
These similarities and dissimilarities imply that YAP/TAZ has 
multifaceted roles in ECs for sprouting angiogenesis.
Mechanistically, we have identified potential actomyosin 
machineries regulated by YAP/TAZ in the ECs stimulated with 
VEGF. Small Rho GTPases are master regulators of the struc-
ture and dynamics of actomyosin cytoskeleton required for cell 
migration, polarization, adhesion, vesicle trafficking, and cell 
cycle (56, 57). Among the molecules, CDC42 is critically required 
for filopodia formation in ECs of angiogenic sprouts (58–61). 
Intriguingly, our results revealed that YAP/TAZ depletion mark-
edly reduces Cdc42 activity in the ECs stimulated with VEGF, 
which could be an underlying mechanism for the impaired shape 
of tip ECs in Yap/TaziΔEC mice. Moreover, YAP/TAZ promotes the 
expression of MLC2, a component of nonmuscle myosin II that 
plays central roles in cell migration, adhesion, and tissue mor-
phogenesis (62). Interestingly, these cytoskeletal regulators are 
also regulated by MRTF/SRF signaling (42).
not mRNA level of MYC in ECs (Figure 10, I and J), which is 
consistent with previous findings in other cells (41). Thus, these 
findings point to MYC as an important functional effector of 
YAP/TAZ in coordinating EC proliferation and metabolism 
during angiogenic sprouting.
Endothelial YAP/TAZ is required for pathological angiogenesis 
but dispensable for maintaining barrier integrity during adulthood. 
We finally asked whether endothelial YAP/TAZ is required 
for maintaining barrier integrity. To answer this question, we 
deleted Yap/Taz in ECs at adulthood (Figure 11A). However, 
Yap/TaziΔEC mice showed no definitively abnormal phenotypes, 
including vascular leakage, in the vessels of retina and brain 
(Figure 11, B–D). We also found that Yap/TaziΔEC mice had sim-
ilar expression and distribution of GLUT1, TfR, and PLVAP in 
brain vessels and PDGFRβ+ pericyte coverage compared with 
WT mice (Figure 11, E and F). These results indicate that endo-
thelial YAP/TAZ is not required for maintaining BBB and BRB 
integrity in adulthood.
We next questioned whether endothelial YAP/TAZ has a sub-
stantial role in pathological angiogenesis during adulthood because 
higher transcriptional or metabolic activity is required to stimulate 
quiescent adult ECs to facilitate pathological neovascularization. 
To answer this question, we used a mouse model of laser-induced 
choroidal neovascularization (CNV) that mimics human neovas-
cular age-related macular degeneration, one of the most common 
forms of ocular neovascular diseases. We specifically deleted Yap/
Taz in the ECs of blood vessels of 8-week-old Yap/TaziΔEC mice and 
performed laser photocoagulation 4 weeks later (Figure 11G). Yap/
TaziΔEC mice exhibited markedly attenuated CNV volume and sup-
pressed vascular leakage compared with WT mice at 7 days after 
laser photocoagulation (Figure 11, H and I). These findings demon-
strate that YAP/TAZ is substantially involved in pathological angio-
genesis during adulthood.
Discussion
In this study, we uncovered crucial roles of YAP/TAZ in mor-
phogenesis, polarization, and migration of tip ECs and prolif-
eration of stalk ECs in the growing vascular front by regulation 
of actin cytoskeleton rearrangement, cell cycle progression, 
and metabolism. Strikingly, the EC-specific deletion of Yap/
Taz resulted in unique morphologic alterations that comprised 
a nonpolarized, microaneurysm-like shape and a disorganized 
actin cytoskeleton with fewer and dysmorphic filopodia in the 
tip ECs. Consequently, sprouting angiogenesis was substan-
tially retarded in both physiological and pathological condi-
tions, providing evidence of the roles of YAP/TAZ as novel reg-
ulators for promoting angiogenesis.
The preferential nuclear localizations of YAP and TAZ in ECs 
of vascular front in growing vessels imply their substantial roles in 
primarily sprouting angiogenesis in response to various stimuli, 
but minor roles in matured and established blood vessels with lit-
tle or no nuclear localizations. In fact, the impaired vascular phe-
notypes in Yap/TaziΔEC mice were mainly detected in the organs 
and at the time when nuclear localizations of YAP and TAZ were 
high. A recent report (21) showed that the blood flow–dependent 
YAP nuclear localization in ECs is independent of the Hippo path-
way. On the other hand, we and others (17) have observed nuclear 
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ysis promotes tip EC migration and stalk EC proliferation in 
the angiogenic front (64). As a downstream metabolic effector, 
MYC is highly enriched in the ECs of sprouting vessels, and its 
depletion reduces both glycolysis and mitochondrial respira-
tion in ECs (40). Moreover, MyciΔEC mice show impaired vas-
cular growth and branching (40), similar to the vascular phe-
notypes of Yap/TaziΔEC mice. A recent study (65) indicates that 
YAP promotes cell proliferation and glycolysis by upregulating 
GLUT3 expression in transformed cell lines. In accordance with 
these studies, our findings indicate that YAP/TAZ promotes not 
only EC proliferation and metabolism but also the expression 
and activity of MYC in the ECs. In this regard, YAP/TAZ may 
regulate proliferation and metabolism through MYC signaling 
in stalk ECs during angiogenic sprouting (Figure 12). However, 
fatty acid oxidation (FAO) is specifically required for EC pro-
liferation during angiogenic sprouting (66), and YAP promotes 
Moreover, a recent study (63) has shown that YAP is indis-
pensable for tissue morphogenesis mediated through a Rho 
GTPase–activating protein, ARHGAP18, to regulate the corti-
cal actomyosin network and filopodia formation in medaka and 
zebrafish. Together, our findings reinforce the idea that actomyo-
sin rearrangement is an essential mediator of YAP/TAZ for direc-
tional migration and filopodia formation of tip ECs during sprout-
ing in response to angiogenic cues (Figure 12). Further detailed 
study is required to ascertain the YAP/TAZ–induced regulations of 
CDC42 and MLC2 and consequent changes in filopodia formation 
and junction assembly in growing vessels.
Emerging results (36–38) have highlighted the importance 
of EC metabolism in controlling the behaviors of tip and stalk 
ECs during angiogenic sprouting. VEGF enhances glycolysis in 
ECs by inducing expression of GLUT1 and glycolytic enzymes 
such as PFKFB3 and LDHA, and this VEGF-enhanced glycol-
Figure 4. Endothelial Yap/Taz deletion leads to sustained and severe impairment of BRB and vision. (A) Diagram depicting the experiment sched-
ule for EC-specific deletion of Yap/Taz in retinal vessels from P2 and their analyses at P21 in Yap/TaziΔEC mice. (B and C) Images of CD31+ vessels in 
superficial and deep layers of retinas and comparisons of indicated parameters in WT (W) and Yap/TaziΔEC (YT) mice (n = 4, each group). Scale bars: 
500 μm. (D) Electroretinography in WT and Yap/TaziΔEC mice. Normal electroretinographic responses as shown by photopic B wave and scotopic a- and 
b- waves in WT mice (black line) are hardly detected in Yap/TaziΔEC mice (red line). Arrows, flash stimuli. Scale bars (green): 40 ms (x) and 40 μV (y) for 
photopic electroretinography; 40 ms (x) and 160 μV (y) for scotopic electroretinography. (E) Comparisons of amplitude of photopic b-wave and scoto-
pic a- and b- waves in WT and Yap/TaziΔEC mice (n = 4, each group). Error bars represent mean ± SD. *P < 0.05 vs. WT by Mann-Whitney U test.
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activity in the CreERT2 mice, tamoxifen was given with the follow-
ing dosages and schedules: for embryos, 2 mg of tamoxifen (Sigma- 
Aldrich, T5648) dissolved in corn oil (Sigma-Aldrich, C8267) was 
injected i.p. into the pregnant mother at E9.5 and E11.5; for neo-
natal mice, 100 μg of tamoxifen was injected either into the stom-
ach or subcutaneously every day from P2 to P4; for adult mice 
aged over 1 month, 2 mg of tamoxifen was injected i.p. over 5 
consecutive days from the indicated time point. For constitutive 
Cre recombination in the Cre mice, Cre-positive male mice and 
Cre-negative female mice were used for intercrossing and embryos 
were obtained at E9.5. For in vivo inhibition of DLL4/Notch sig-
naling, 100 mg/kg of γ-secretase inhibitor (DAPT; N-[N-(3,5- 
difluorophenacetly)-l-alanyl]-S-phenylglycine t-butyl ester) (Cal-
biochem, 565770) dissolved in corn oil was injected subcutaneously 
at P5 and P6 after tamoxifen administration, and the retinas were 
harvested at P7. For anesthesia, mice were injected i.p. with the anes-
thetic solution (ketamine 40 mg/kg and xylazine 5 mg/kg).
Laser-induced CNV mouse model. Generation of the laser-induced 
CNV mouse model was performed using approximately 8-week-old 
male mice according to a previously described method (72) with some 
modifications (73). After dilation of pupils with 1% tropicamide and 
2.5% phenylephrine eye drops (Santen Pharmaceutical) and instilla-
tion of 0.5% proparacaine hydrochloride eye drops (Alcon) for topical 
anesthesia, a laser photocoagulator (Lightmed, LIGHTLas 532) with a 
slit lamp delivery system was used with a glass coverslip as a contact 
lens to visualize the retina. Sufficient laser energy (532 nm wavelength, 
250 mW power, 100 ms duration, 50 μm spot size) was delivered in 4 
locations for each eye (the 3, 6, 9, and 12 o’clock positions of the pos-
terior pole). Only burns that produced a bubble at the time of laser 
photocoagulation, indicating the rupture of the Bruch membrane, were 
included in this study. Spots containing hemorrhage at the laser site 
were excluded from the analysis.
Vascular permeability assay. For dextran leakage assay, FITC- 
conjugated dextran (70 kDa; Sigma-Aldrich, 46945) was injected 
at a concentration of 25 mg/ml into the retro-orbital plexus 30 min-
utes before harvesting of brains. For Evans blue (EB) leakage assay, 
100 μl of EB (2% in PBS; Sigma-Aldrich, E2129) was injected i.p. 24 
hours before harvesting of brains. To quantify EB leakage in brains, 
harvested brains were homogenized and incubated in formamide for 
24 hours at 55°C. Supernatants were collected and EB was measured 
at the absorbance of 620 nm. EB concentrations were normalized by 
control, calculated from a standard curve of EB in formamide, and 
presented as fold difference.
Confocal scanning laser fluorescein angiography and indocyanine 
green angiography. Using a custom-built confocal scanning laser reti-
nal angiography system (74), in vivo fundus fluorescein angiography 
(FA) and indocyanine green angiography (ICGA) of the CNV lesion 
were performed. Continuous-wave laser modules at 488 nm and 785 
nm were used as excitation sources for fluorescein and indocyanine 
green, respectively. A raster scanning pattern of excitation lasers was 
achieved by a scanner system consisting of a rotating polygonal mir-
ror (Lincoln Laser, MC-5) and a galvanometer-based scanning mirror 
(Cambridge Technology, 6230H), and delivered to the back aperture 
of an imaging lens. A high numerical aperture (NA) objective lens 
(PlanApo λ, NA 0.75; Nikon) was used as the imaging lens to provide 
wide-field fundus fluorescence images. Fluorescence signals detected 
by photomultiplier tubes (Hamamatsu Photonics, R9110) were digi-
expression of CPT1A, a rate-limiting enzyme of FAO in ECs 
(67). Thus, it would be worth examining whether YAP/TAZ 
controls FAO activity in ECs.
This study also demonstrates that YAP/TAZ is critically 
required for formation and maturation of the BRB and BBB. Build-
ing of the BRB and BBB begins with coordinated induction of 
proteins that maintain tight and adherens junctions and nutrient 
transporters on the ECs at the onset of vascular branching and 
network formation, followed by maturation of the barrier proper-
ties along with close interactions with pericytes and Müller cells, 
glial cells, or astrocytes in retina and brain (68–70). Notably, the 
assembly and maturation of junctional complexes are intimately 
linked to the actomyosin dynamics and the activity of small Rho 
GTPases such as CDC42 (61, 71), which can be regulated by YAP/
TAZ. Thus, the impairments in the BRB and BBB in Yap/TaziΔEC 
mice appear to be caused by multiple defects in these sequential 
processes, implying that YAP/TAZ as a transcriptional coactivator 
plays multiple roles in differentiation and maturation of the grow-
ing vessels. YAP/TAZ is dispensable for maintaining blood-barrier 
integrity during adulthood, but it contributes to inducing patho-
logical angiogenesis. Thus, YAP/TAZ plays dynamic roles in the 
ECs of growing vessels, which require high levels of cell dynamic 
transcription or metabolism.
Together, the findings of this study delineate the essential 
roles of YAP/TAZ for sprouting angiogenesis and barrier matu-
ration and identify their multifaceted actions as core transcrip-
tional regulators mediating angiogenic signals and navigating EC 
behaviors. These behaviors include directional migration, prolif-
eration and metabolism, and junction assembly, illuminating the 
complexity and delicate control of angiogenesis. Our results also 
provide a basis for targeting vascular sprouting as a potential ther-
apeutic strategy for pathological angiogenesis.
Methods
Supplemental Methods are available online with this article; https://
doi.org/10.1172/JCI93825DS1.
Mice and treatment. Specific pathogen–free (SPF) C57BL/6J 
mice and Tie2-Cre mice were purchased from the Jackson Labo-
ratory. VE-cadherin–CreERT2 (25), Yapfl/fl (23), Tazfl/fl (24), Lats1fl/fl 
(26, 27), and Lats2fl/fl (33) mice were transferred, established, and 
bred in our SPF animal facilities at KAIST and fed with free access 
to a standard diet (PMI LabDiet) and water. In order to induce Cre 
Figure 5. Endothelial Yap/Taz deletion leads to extensive and multifocal 
brain hemorrhage. (A) Diagram depicting the experiment schedule for Yap/
Taz deletion in brain ECs from P2 and their analyses at P12 in Yap/TaziΔEC 
mice. (B and C) Images of whole and sectioned brains. Severe hemorrhage is 
detected in cerebral striatum and nuclei, and cerebellum (arrows). (D) H&E 
staining of brain sections at indicated areas. Brain hemorrhage (arrows) is 
detected in Yap/TaziΔEC mice. Scale bars: 100 μm. (E and F) Images of whole 
and sectioned brains and comparison of Evans blue (EB) leakage in brains 
after EB injection in WT and Yap/TaziΔEC mice (n = 4, each group). (G and H) 
Images and comparisons of TER119+ rbc leakage and F4/80+ macrophage 
infiltration in cerebral striatum of WT and Yap/TaziΔEC mice (n = 5, each 
group). Scale bars: 100 μm. (I and J) Images and comparisons of FITC- 
conjugated dextran (70 kDa) leakage in the indicated areas of WT and Yap/
TaziΔEC brains (n = 5, each group). Scale bars: 100 μm. Error bars represent 
mean ± SD. *P < 0.05 vs. WT by Mann-Whitney U test.
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and b- waves were presented by the LabScribe ERG version 3 software 
and used for analyses.
Cell culture. Pooled primary cultured HUVECs were purchased 
from Lonza. HUVECs were cultured in EGM-2 media (Lonza) in cul-
ture dishes coated with 0.1% gelatin. HUVECs at passages 3–6 were 
used for this study.
RNA interference. HUVECs were transfected with a pool of siRNAs 
using Lipofectamine RNAiMAX (Invitrogen) according to the man-
ufacturer’s protocols. The following target sequences were used: 
human YAP (5′-GACAUCUUCUGGUCAGAGA-3′) and human TAZ 
(5′-ACGUUGACUUAGGAACUUU-3′). GL2 siRNA (5′-CGTACGCG-
GAATACTTCGA-3′) was used as negative control. Cells were harvested 
48–72 hours after transfection. Efficiency of knockdown was evaluated 
by immunoblotting.
Cell growth assay and cell cycle analysis. Cell proliferation was 
measured using the Cell Counting Kit-8 reagent (CCK-8, Dojindo). 
HUVECs were seeded into a 96-well plate at 3 × 103 cells per well 
and cultured for 24 hours. Then, 10 μl CCK-8 was treated to each 
well after 0, 24, 48, and 72 hours. Measurements were taken at the 
absorbance of 450 nm at 2 hours after treatment of CCK-8. For cell 
cycle analysis, HUVECs were incubated with 10 μM BrdU for 4 hours 
and were processed with the APC BrdU flow kit (BD Biosciences) 
following the manufacturer’s protocols. The cell cycle profiles were 
characterized with a FACS Canto II (BD Biosciences) and analyzed 
with FlowJo (Tree Star).
Metabolic assays. The extracellular acidification rate (ECAR) 
and oxygen consumption rate (OCR) were measured using the 
Seahorse XFe96 analyzer (Seahorse Bioscience) following the 
manufacturer’s instructions. Briefly, ECAR and OCR were mea-
sured 6 hours after seeding of HUVECs (20,000 cells per well) 
on 0.1% gelatin-coated XFe96 microplates. HUVECs were main-
tained in nonbuffered assay medium in a non-CO2 incubator for 
1 hour before the assay. The Glycolysis stress test kit (Seahorse 
Bioscience) was used to monitor ECAR under various conditions. 
Three baseline recordings were made, followed by sequential 
injections of glucose (10 mM), the mitochondrial/ATP synthase 
inhibitor oligomycin (3 μM), and the glycolysis inhibitor 2-deoxy-d- 
glucose (100 mM). The Mito stress test kit (Seahorse Bioscience) was 
used to assay the OCR under basal conditions in the presence of oli-
gomycin (3 μM), the mitochondrial uncoupler carbonyl cyanide-4- 
(trifluoromethoxy)phenylhydrazone (FCCP; 1 μM), and the respira-
tory chain inhibitors rotenone and antimycin A (1.5 μM).
Measurement of the GTP-bound forms of RhoA, Rac1, and CDC42. 
HUVECs were incubated for 24 hours in EBM-2 media (Lonza) to 
starve the cells, and then treated with 50 ng/ml VEGF for 30 min-
utes. Cell lysates were collected, and levels of activated GTP-bound 
RhoA, Rac1, and CDC42 were determined using the G-LISA RhoA 
(BK121), Rac1 (BK126), and CDC42 (BK127) Activation Assay Bio-
chem Kits (Cytoskeleton Inc.).
Wound healing assay. The migration of HUVECs was measured 
using a Culture-Insert 2 Well (ibidi GmbH) according to the manu-
facturer’s instructions. Briefly, 48–72 hours after siRNA transfection, 
cells were seeded into culture inserts and were incubated to allow 
them to adhere. The culture insert provided 2 cell culture reser-
voirs that were separated by an approximately 500-μm-thick wall. 
After removal of the culture inserts on the second day, a “wound” of 
approximately 500 μm was formed between the 2 cell patches. Photos 
tized by frame grabber and reconstructed to images with a size of 512 
× 512 pixels per frame in real time. To visualize late-phase (6 min-
utes) FA and ICGA images using the angiography system, 10 mg of 
fluorescein sodium (Alcon) and 0.15 mg of indocyanine green (Daii-
chi Pharmaceutical) were administered i.p. and i.v., respectively. 
The imaging procedure was performed under systemic anesthesia 
and pupil dilation to improve the quality of images. Leaky areas from 
CNV were calculated as the total measured hyperfluorescent areas in 
FA images divided by the total measured CNV areas in ICGA images 
using ImageJ (NIH).
Transmission electron microscopy. To visualize EC junction of 
brain vessels in high magnification, brain was harvested and sec-
tioned after perfusion-fixation with 4% paraformaldehyde and 
0.25% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). The tissues 
were then fixed overnight in 2.5% glutaraldehyde in 0.1 M phosphate 
buffer (pH 7.4), postfixed with 1% osmium tetroxide, and dehydrated 
with series of increasing ethanol concentration followed by resin 
embedding. Ultrathin sections (70 nm) were obtained with an ultra-
microtome (Leica, UltraCut UCT) and then collected on copper grids. 
After staining with 2% uranyl acetate and lead citrate, transmission 
electron microscopy was performed using a microscope (FEI Tecnai, 
G2 Spirit Twin) operated at 120 kV.
Electroretinography. Electroretinography was recorded to assess 
retinal neuronal function at the indicated time points. Mice were either 
dark- or light-adapted for 12 hours before electroretinographic monitor-
ing, anesthetized, and placed on a heating pad to maintain body tem-
perature. After dilation of pupils with 1% tropicamide and 2.5% phen-
ylephrine eye drops (Santen Pharmaceutical), cornea was placed on a 
gold-plated objective lens, while silver-embedded needle electrodes 
were placed at forehead (reference) and tail (ground). The electro-
retinographic stimulus and recording were performed using LabScribe 
ERG version 3 software combined with a retinal imaging microscope 
(Phoenix Research Labs, Micron IV) following the manufacturer’s 
instructions. To obtain scotopic (dark-adapted condition) a- and b- 
waves, a digital bandpass filter ranging from 0.3 to 1,000 Hz and stimu-
lus ranging from –2.2 to 2.2 log(cd·s/m2) were used. To obtain photopic 
(light-adapted condition) b-waves, a filter ranging from 2 to 200 Hz and 
stimulus ranging from 0.4 to 2.2 log(cd·s/m2) with 1.3 log(cd·s/m2) back-
ground were used. After averaging of the signals, the amplitudes of a- 
Figure 6. Endothelial YAP/TAZ is required for vascular network formation 
in brain. (A) Diagram for EC-specific deletion of Yap/Taz in brain vessels 
from P2 and their analyses at P12 in Yap/TaziΔEC mice. (B and C) Images of 
CD31+ vessels of cerebral cortex and striatum, and comparisons of indicated 
parameters in WT and Yap/TaziΔEC mice (n = 5, each group). The yellow 
dashed line demarcates the border between cortex and striatum. Scale 
bars: 500 μm. (D and E) Magnified images of tip ECs and comparisons of 
indicated parameters in WT and Yap/TaziΔEC mice (n = 5, each group). Tip 
ECs of Yap/TaziΔEC mice exhibit an aneurysm-like structure with less and 
dysmorphic filopodia (white arrowheads). Scale bars: 25 μm. (F and G) 
Images and comparisons of levels of glucose transporter 1 (GLUT1), transfer-
rin receptor (TfR), PLVAP, and PDGFRβ+ pericyte coverage onto CD31+ vessels 
in cerebral striatum of WT and Yap/TaziΔEC mice (n = 5, each group). Scale 
bars: 50 μm. (H) Diagram for EC-specific deletion of Yap/Taz from P2 and 
sampling of brain ECs and their analyses at P8 in Yap/TaziΔEC mice. (I) GSEA 
of isolated brain ECs showing downregulation of YAP signature genes in 
Yap/TaziΔEC compared with those in WT mice, and correspondent heat-
maps of the top 15 enriched genes. ES, enrichment score; NES, normalized 
enrichment score. Error bars represent mean ± SD. *P < 0.05 vs. WT by 
Mann-Whitney U test.
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559864), and APC-conjugated rat anti-TER119 (BD Pharmingen, 
557909). To discriminate dead cells, cells were stained with DAPI 
(Sigma-Aldrich) and cell sorting was performed with FACSAriaII (BD 
Biosciences). Data were analyzed using FlowJo software (Tree Star). 
Lung EC isolation was performed with the same method as described 
above but without enrichment of CD31+ cells by AutoMACS.
RNA sequencing and accession numbers. After extraction of total 
RNA from cells using Trizol reagent (Invitrogen), RNA quality was 
assessed by an Agilent 2100 bioanalyzer using the RNA 6000 
Nano Chip (Agilent Technologies), and RNA quantification was 
performed using an ND-2000 Spectrophotometer (Thermo Fisher 
Scientific). RNA sequencing (RNA-Seq) was performed with TruSeq 
RNA Library Prep kit v2 and NextSeq 500 equipment (Illumina). 
Mapping of RNA-Seq reads was performed using the TopHat soft-
ware tool so as to acquire the alignment file, which was used to 
bring together transcripts, assess their exuberances, and identify 
of the wound were taken after 12 hours. The widths of the wounds 
were analyzed using ImageJ.
Isolation of brain and lung ECs. After anesthesia, brain was har-
vested at P8, cut into small pieces, and digested in buffer containing 
0.1% collagenase type 1A (Worthington) and 3 U/ml DNase I (Roche) 
at 37°C for 45 minutes. Tissues were gently agitated, strained with 
a 40-μm nylon mesh to remove cell clumps, and incubated in ACK 
lysis buffer for 2 minutes to remove erythrocytes. Single-cell suspen-
sions were incubated for 30 minutes with biotin-conjugated rat anti-
CD31 (Miltenyi Biotec, 130-101-955), washed to remove unbound 
antibody, and incubated for 20 minutes with anti-biotin microbeads 
(Miltenyi Biotec, 130-090-485). CD31+ cells were enriched using an 
AutoMACS Pro Separator (Miltenyi Biotec). Enriched cells were fur-
ther stained with the following antibodies: PE-conjugated rat anti-
CD31 (BD Pharmingen, 553373), PE-conjugated streptavidin (eBio-
science, 12-4317), APC-conjugated rat anti-CD45 (BD Pharmingen, 
Figure 8. VEGF upregulates YAP/TAZ transcriptional activity in ECs. (A and B) Images and quantification of the nuclear enrichment of YAP in 
HUVECs stimulated with VEGF (50 ng/ml) for 30 minutes (n = 4, each group). Scale bars: 20 μm. (C and D) Immunoblot analyses and comparisons of 
indicated proteins in HUVECs stimulated with VEGF (50 ng/ml) for indicated times (n = 3, each group). Note that, upon VEGFR2 activation, the level 
of pLATS1 (Thr1079) is reduced after 5 minutes, and reduction in pYAP (Ser127) level follows after 30 minutes. (E) Quantitative PCR analysis of CTGF 
and CYR61 mRNA levels in HUVECs stimulated with VEGF for 1 hour (n = 4, each group). (F) GSEA of the microarray data (GSE18913) showing upregu-
lation of YAP signature genes in HUVECs stimulated with VEGF for 1 hour compared with control. ES, enrichment score; NES, normalized enrichment 
score. Error bars and dots represent mean ± SD. *P < 0.05 vs. control or 0 minutes by Mann-Whitney U test.
Figure 7. Endothelial YAP/TAZ is indispensable for BBB maturation. (A) Diagram for EC-specific deletion of Yap/Taz in brain vessels from P2 and their anal-
yses at P12 in Yap/TaziΔEC mice. (B and C) Images and comparisons of distributions of VE-cadherin, ZO1, and claudin-5 on CD31+ vessels in cerebral striatum of 
WT and Yap/TaziΔEC mice (n = 5, each group). Scale bars: 50 μm. (D) Electron microscopic images showing electron-dense and continuous junction between 
brain ECs in WT mice (arrows), while junction between ECs is disrupted and less electron-dense in Yap/TaziΔEC mice (arrowheads). Scale bars: 1 μm. (E and 
F) Images and comparisons of levels of COL4, laminin, nidogen, and perlecan on CD31+ vessels in cerebral striatum of WT and Yap/TaziΔEC mice (n = 5, each 
group). Scale bars: 50 μm. (G) Comparisons of expressions of indicated mRNA in brains of WT and Yap/TaziΔEC mice (n = 4, each group). (H) GSEA showing 
downregulated GO terms “cell junction assembly” and “extracellular structure organization” in brain ECs of Yap/TaziΔEC mice compared with those of WT 
mice. ES, enrichment score; NES, normalized enrichment score. Error bars represent mean ± SD. *P < 0.05 vs. WT by Mann-Whitney U test.
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Figure 9. YAP/TAZ depletion impairs EC migration and filopodia/lamellipodia formation by suppressing CDC42 and MLC2 activity. (A and B) Images and 
comparison of wound healing migration in HUVECs transfected with siCont (siCont-ECs) or siYAP/TAZ (siYAP/TAZ-ECs) (n = 4, each group). Scale bars: 500 
μm. (C and D) Images of phalloidin+ actin cytoskeleton and comparisons of indicated parameters in siCont-ECs and siYAP/TAZ-ECs after VEGF stimulation 
for 30 minutes (n = 4, each group). Scale bars: 20 μm. (E) Immunoblot analyses of indicated proteins in siCont-ECs and siYAP/TAZ-ECs stimulated with VEGF 
for indicated times. Similar findings were observed in 3 independent experiments. (F) Comparisons of activities of RhoA, Rac1, and CDC42 in siCont-ECs and 
siYAP/TAZ-ECs stimulated with VEGF for 30 minutes (n = 4, each group). Note that siYAP/TAZ-ECs show markedly attenuated CDC42 activity. (G and H) 
Immunoblot analyses and comparisons of indicated proteins in siCont-ECs and siYAP/TAZ-ECs (n = 3, each group). Note that siYAP/TAZ-ECs show selectively 
reduced protein level of CDC42. (I) Immunoblot analyses and comparisons of indicated proteins in siCont-ECs and siYAP/TAZ-ECs (siY/T) (n = 3–4, each group). 
Numbers indicate mean ± SD. Note that siYAP/TAZ-ECs show significantly reduced MLC2, a key regulator of contractile force. (J and K) Images and comparison 
of pMLC2 (at Ser19) in CD31+ retinal vessels at P5 in WT and Yap/TaziΔEC mice (n = 4, each group). Scale bars: 100 μm. (L) GSEA of isolated brain ECs showing 
downregulated GO term “regulation of actin filament based movement” in Yap/TaziΔEC mice compared with WT mice. ES, enrichment score; NES, normalized 
enrichment score. Error bars represent mean ± SD. *P < 0.05 vs. siCont or WT mice by Mann-Whitney U test.
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Figure 10. YAP/TAZ positively regulates proliferation and metabolic activity of ECs through MYC signaling. (A and B) Growth and cell cycle analysis of 
HUVECs transfected with siCont (siCont-ECs) or siYAP/TAZ (siYAP/TAZ-ECs) (n = 4, each group). (C and D) Comparisons of extracellular acidification rate 
(ECAR) of siCont-ECs (siC) and siYAP/TAZ-ECs (siYT) under basal conditions and in response to glucose, oligomycin (Oligo), and 2-deoxy-d-glucose (2-DG) 
(n = 5, each group). (E and F) Comparisons of oxygen consumption rate (OCR) of siCont-ECs and siYAP/TAZ-ECs under basal conditions and in response 
to oligo, fluoro-carbonyl cyanide phenylhydrazone (FCCP), and antimycin A (AA)/rotenone (R) (n = 5, each group). (G) GSEA of isolated brain ECs showing 
downregulations of E2F target, glycolysis, and oxidative phosphorylation signature genes in Yap/TaziΔEC compared with WT mice. ES, enrichment score; 
NES, normalized enrichment score. (H) Heatmap of MYC signature genes of brain ECs sorted from WT and Yap/TaziΔEC mice. (I and J) Quantitative PCR  
(n = 4, each group) and immunoblot analysis of MYC expression in siCont-ECs and siYAP/TAZ-ECs. Error bars represent mean ± SD. *P < 0.05 vs. siCont  
by Mann-Whitney U test.
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differentially expressed genes or isoforms using cufflinks. All gene 
expression values from RNA-Seq were changed to log2 values and 
analyzed further. Then gene set enrichment analysis (GSEA) was 
performed with version 5.2 of the Molecular Signatures Database 
(http://www.broadinstitute.org/gsea/msigdb), and the gene sets 
that had less than 0.05 nominal P value were stated. The original 
data are available in the National Center for Biotechnology Informa-
tion’s Gene Expression Omnibus (accession nos. GSE94673, brain 
ECs, and GSE94685, lung ECs).
Statistics. Values are presented as mean ± SD. Statistical signifi-
cance was determined by the 2-sided Mann-Whitney U test between 
2 groups or the Kruskal-Wallis test followed by Tukey’s honest signifi-
cant difference test with ranks for multiple-group comparison. Survival 
curve was evaluated using the Kaplan-Meier method, and statistical 
differences were analyzed using the log-rank test. Statistical analysis 
was performed using GraphPad Prism 7.0 (GraphPad Software). Statis-
tical significance was set to P value less than 0.05.
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mittee (no. KA2016-39) of Korea Advanced Institute of Science and Tech-
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Use of Animals in Ophthalmic and Vision Research.
Figure 12. Schematic diagram depicting the roles 
of YAP/TAZ in sprouting angiogenesis and vascu-
lar barrier maturation. In response to VEGF, YAP/
TAZ binds to TEAD family transcriptional factors, 
and positively controls activity of Cdc42 and MLC2 
for actomyosin contractility, which are essential for 
filopodia formation and cell migration in tip ECs. 
Simultaneously, YAP/TAZ upholds expression and 
activity of MYC signaling, which is a key driver of EC 
metabolism and growth, thereby promoting cell pro-
liferation in stalk ECs and maturation in barrier ECs 
forming the BBB. Along with angiogenic sprouting, 
YAP/TAZ also promotes formation and maturation 
of vascular barrier by upregulating expressions of 
junctional molecules and ECM components.
Figure 11. Endothelial YAP/TAZ is required for pathological angiogenesis, but dispensable for the maintenance of barrier integrity during adulthood. (A) Dia-
gram for EC-specific deletion of Yap/Taz in retinal and brain vessels of 8-week-old mice and their analyses after 4 weeks in Yap/TaziΔEC mice. (B and C) Images of 
CD31+ retinal vessels and comparisons of indicated parameters in WT and Yap/TaziΔEC mice (n = 4, each group). Scale bars: 500 μm, top panels; 100 μm, bottom 
panels. (D) Images of whole and sectioned brains from WT and Yap/TaziΔEC mice. No visible hemorrhage or EB leakage is detected in both mice. (E and F) Images 
and comparisons of levels of GLUT1, TfR, PLVAP, and PDGFRβ+ pericyte coverage onto CD31+ vessels in cerebral striatum of WT and Yap/TaziΔEC mice (n = 5, each 
group). Scale bars: 50 μm. (G) Diagram for EC-specific deletion of Yap/Taz in retinal vessels of 8-week-old mice, generation of choroidal neovascularization (CNV) 
4 weeks later, and their analyses at 2 weeks after laser photocoagulation in Yap/TaziΔEC mice. (H) Images of late-phase fluorescein angiography (FA) for detecting 
vascular leakage surrounding the site of laser injury, and indocyanine green angiography (ICGA) and CD31 staining of retinal pigment epithelium–choroid–sclera 
flat mounts for quantifying the extent of CNV in WT and Yap/TaziΔEC mice. Scale bars: 100 μm. (I) Comparisons of CNV volumes calculated by total measure-
ments of CD31+ CNV volume, and leaky areas from CNV calculated as total measured hyperfluorescent areas in FA images divided by total measured CNV areas 
in ICGA images, in WT and Yap/TaziΔEC mice (n = 5, each group). Error bars represent mean ± SD. *P < 0.05 vs. WT by Mann-Whitney U test.
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